• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ROCHE DIAGNOSTICS TINA-QUANT LIPOPROTEIN (A) GEN. 2; LIPOPROTEIN, LOW-DENSITY, ANTIGEN, ANTISERUM, CONTROL

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ROCHE DIAGNOSTICS TINA-QUANT LIPOPROTEIN (A) GEN. 2; LIPOPROTEIN, LOW-DENSITY, ANTIGEN, ANTISERUM, CONTROL Back to Search Results
Catalog Number 08106126190
Medical Device Problem Code Non Reproducible Results (4029)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 03/07/2024
Type of Reportable Event Malfunction
Additional Manufacturer Narrative
The lipoprotein a reagent lot number was 73658701 with an expiration date of 31-dec-2024.The investigation is ongoing.
 
Event or Problem Description
The initial reporter stated they received discrepant results for one patient sample tested with lpa2 (lipoprotein a) on a cobas c 503 analytical unit.No questionable results were reported outside of the laboratory.The sample initially resulted in a lipoprotein a value of 52.1 mg/dl with a data flag.The sample was automatically repeated by the analyzer, resulting in a value of 46 mg/dl.The sample was repeated three times on a second analyzer, resulting in values of 35 mg/dl, 35 mg/dl, and 34.0 mg/dl with a data flag.The repeat value of 35 mg/dl was deemed correct.
 
Additional Manufacturer Narrative
Calibration and controls were acceptable.The field service engineer performed precision studies and these were acceptable.The investigation could not identify a product problem.The cause of the event could not be determined.Medwatch fields d1, d2, d4, g1, and g4 have been updated.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
TINA-QUANT LIPOPROTEIN (A) GEN. 2
Common Device Name
LIPOPROTEIN, LOW-DENSITY, ANTIGEN, ANTISERUM, CONTROL
Manufacturer (Section D)
ROCHE DIAGNOSTICS
9115 hague road
indianapolis IN 46250 0457
Manufacturer (Section G)
ROCHE DIAGNOSTICS GMBH
sandhofer strasse 116
mannheim (baden-wurttemberg) 68305
GM   68305
Manufacturer Contact
amy nelson
9115 hague road
indianapolis, IN 46250-0457
MDR Report Key18959781
Report Number1823260-2024-00870
Device Sequence Number4579656
Product Code DFC
UDI-Device Identifier07613336140833
UDI-Public07613336140833
Combination Product (Y/N)Y
Initial Reporter StateUT
Initial Reporter CountryUS
PMA/510(K) Number
K122722
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)Unknown
Reporter Type Manufacturer
Report Source Health Professional,User Facility
Initial Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date (Section B) 04/17/2024
2 Devices were Involved in the Event: 1   2  
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Expiration Date12/31/2024
Device Catalogue Number08106126190
Device Lot Number73658701
Was Device Available for Evaluation? Yes
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Follow-Up
Initial Date Received by Manufacturer 03/08/2024
Supplement Date Received by Manufacturer04/15/2024
Initial Report FDA Received Date03/22/2024
Supplement Report FDA Received Date04/17/2024
Was Device Evaluated by Manufacturer? (Y/N) Yes
Is the Device Labeled for Single Use? (Y/N) No
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Patient Sequence Number1
Patient SexUnknown
-
-